title: Factors affecting in vitro protein binding of etoposide in humans.
abstract: Clinical studies have demonstrated that the plasma protein binding of etoposide, a widely used anticancer drug, is extensive (approximately 94%), highly variable among patients (10-fold range), and significantly related to serum albumin and total bilirubin concentration. The present study was designed to more thoroughly evaluate factors likely to affect etoposide protein binding under controlled in vitro conditions where single variables could be changed. Protein binding was determined using an equilibrium dialysis method with tritiated etoposide. The binding of etoposide was similar in serum or plasma, and heparin had no effect on binding. Etoposide binding decreased with increased pH, but no clinically significant difference was noted within the range of physiologic pH. Etoposide binding evaluated in single-source donor plasma was concentration-dependent over a concentration range of 1 to 250 micrograms/mL. Etoposide binding parameters determined in normal human plasma were characterized by a single class of binding sites of moderate affinity (K = 2.88 +/- 0.47 x 10(4)) and high capacity (nP = 5.07 +/- 0.5 x 10(-4); where n is the number of binding sites). The etoposide binding ratio was significantly correlated with albumin concentration (r2 = 99%, p less than 0.05). The characteristics of etoposide binding in a 4.0-g/dL solution of human serum albumin (K = 3.56 +/- 1.22 x 10(4) and nP = 5.58 +/- 0.16 x 10(-4)) suggest that the single class of binding sites is on albumin. Bilirubin caused a significant decrease in K, consistent with competitive binding, but only at higher bilirubin concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee-Memphis 38163.
authors.forename: R A
authors.initials: RA
authors.lastname: Fleming
authors.forename: W E
authors.initials: WE
authors.lastname: Evans
authors.forename: S G
authors.initials: SG
authors.lastname: Arbuck
authors.forename: C F
authors.initials: CF
authors.lastname: Stewart
mesh_terms: D001663:Bilirubin / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism*; D004355:Drug Stability; D005047:Etoposide / Q000097:blood*; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009961:Orosomucoid / Q000378:metabolism; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism
chemical_list: D001798:Blood Proteins; D009961:Orosomucoid; D012709:Serum Albumin; D005047:Etoposide; D006493:Heparin; D001663:Bilirubin